Last update :
19/11/2024
References   References 2988  
Type : Journal

Research teams : Ghent - laboratory of Pharmaceutical technology, State University of Gent
Authors : Huyghebaert N, de Beer J, Vervaet C et al.
Title : Compounding of vitamin A, D3, E, and K3 supplements for cystic fibrosis patients: formulation and stability study.
Reference : J Clin Pharm Ther ; 32: 489-496. 2007

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
CapsuleAlpha-tocopherol acetate Vitamin
Stability in solutions Glass powder 100 mg
Alpha tocophérol acétate
Lactose 185 mg
25°C Not specified
60 Day
Stability in solutions Glass powder 100 mg
Alpha tocophérol acétate
Lactose 185 mg
8°C Protect from light
60 Day
CapsuleCholecalciferol Vitamin
Stability in solutions Glass powder 1000 UI
Cholecalciferol
Lactose 295 mg
25°C Not specified
60 Day
Stability in solutions Glass powder 1000 UI
Cholecalciferol
Lactose 295 mg
8°C Protect from light
60 Day
CapsuleMenadione Vitamin
Stability in solutions Glass powder 1 mg
Menadione
Lactose 190 mg
25°C Not specified
60 Day
Stability in solutions Glass powder 1 mg
® ? = DMS
Lactose 190 mg
8°C Protect from light
60 Day
CapsuleRetinol Vitamin
Stability in solutions Glass powder 10 000 UI
retinol acetate
Lactose 264 mg
25°C Not specified
60 Day
Stability in solutions Glass powder 10 000 UI
Retinol acetate
Lactose 264 mg
8°C Protect from light
60 Day

  Mentions Légales